TS
NVNO

Tamar Securities’s enVVeno Medical NVNO Stock Holding History

Tamar Securities’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$12.7K – 98
2025
Q3 		$12.7K Hold
400
– – ﹤0.01% 90
2025
Q2 		$55.8K Hold
400
– – 0.01% 81
2025
Q1 		$36.8K Hold
400
– – 0.01% 78
2024
Q4 		$42.3K Hold
400
– – 0.01% 72
2024
Q3 		$47K Hold
400
– – 0.01% 71
2024
Q2 		$73.4K Hold
400
– – 0.01% 66
2024
Q1 		$76.1K Hold
400
– – 0.01% 70
2023
Q4 		$71.9K Hold
400
– – 0.01% 61
2023
Q3 		$75.4K Hold
400
– – 0.02% 62
2023
Q2 		$43.1K Buy
+400
New +$51.9K 0.01% 60

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tamar Securities's NVNO Position: Q4 2025 in Review

Tamar Securities sold out of enVVeno Medical (NVNO) in Q4 2025, closing a stake of 400 shares — an estimated $12.7K sold.

Tamar Securities first reported a position in NVNO in Q2 2023 and held it in 10 quarters. The position peaked at $76.1K in Q1 2024. 36 funds tracked by Wall St. Rank hold NVNO as of Q4 2025.

  • Tamar Securities reported no remaining enVVeno Medical position as of Q4 2025 after selling out during the quarter.
  • Tamar Securities sold 400 enVVeno Medical shares in Q4 2025, an estimated $12.7K.
  • Tamar Securities first reported a position in enVVeno Medical in Q2 2023 and held it in 10 quarters.
  • Tamar Securities's enVVeno Medical position peaked at $76.1K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2025.

Based on Tamar Securities's 13F filing for Q4 2025, filed 13 Feb 2026.